CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
B-BRIGHTER focuses on developing an advanced bioprinting technology that enhances the production of engineered tissues with high spatial resolution and speed. By utilizing a unique top-down lithography approach, it aims to create complex tissue models for applications in cell therapy and drug testing.
Bioprinting is considered the most promising method to produce functional engineered tissues with physiological properties.
Successful tissue engineering will open research avenues for drug testing and therapeutic and will therefore raise much interest not only in the academia, but also pharma and clinical sectors.
Current bioprinting methods are limited by combinations of insufficient speed, spatial resolution and cell viability.
Since these technologies often suffer from poor spatial resolutio…
MYCRONIC AB
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Germany, Frankfurt Am Main
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
TECHNION - ISRAEL INSTITUTE OF TECHNOLOGY
Israel, Haifa
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Germany, Reutlingen
Type: SME
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
SME: Yes
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.